Notice - Prescription Drug List (PDL): Hydrocortisone

Notice - Prescription Drug List (PDL): Hydrocortisone The purpose of this Notice of Amendment is to announce the revised listing for hydrocortisone on the Prescription Drug List (PDL). 2023-09-29 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyHydrocortisonenoticenotice of amendmentprescription drug listPDLrevised listing Notice - Prescription Drug List (PDL): HydrocortisoneHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-hydrocortisone.html Notice - Prescription Drug List (PDL): HydrocortisoneHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/hydrocortisone.html

The purpose of this Notice of Amendment is to announce the revised listing for hydrocortisone on the Prescription Drug List (PDL).

Data and Resources

Similar records